AWARDBPA CALLSmall business
BPA call 75F40124F19031SPATIAL FRONT INCORPORATED
Overview
Award facts
- Net obligations
- $4.40M
- $4,399,657of $9.69M potential value
- Outlays (paid to date)
- $3.07M
- $3.07M paid of $4.40M obligated$3,073,546
- Period of performance
- Jan 9, 2024 to Feb 12, 2027
- Ends in 2 months
- Modifications
- 4
- Latest action Oct 28, 2026
- Contract type
- BPA call
- PIID 75F40124F19031
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
LABOR HOUR AWARD CDER OFFICE OF NEW DRUGS (OND) - MODERNIZING THE SCIENCE OF SAFETY DATA ANALYSES SUPPORT COR: NIKISHA REID NIKISHA.REID@FDA.HHS.GOV CS: KIMBERLY DAVIS KIMBERLY.DAVIS@FDA.HHS.GOV NOTICE TO PROCEED WAS ISSUED ON 12/29/2023 EFF
Dates and value
- Award date
- Signed on Jan 9, 2024
- Potential end of performance
- Feb 12, 2030
- Current value
- $4,399,657Base and exercised options
- Potential value (if all options are exercised)
- $9,692,140
- Parent contract vehicle
- 75F40121A00017 (BPA, single award) — 58 orders recorded under it
Obligations by fiscal year of action
- FY2026: $1,299,875
- FY2025: $1,299,875
- FY2024: $1,799,907
Total across 3 fiscal years: $4,399,657
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 28, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationBETHESDA, MD
UEIJ1ADW6BL8MN5
CAGE code5XGW3
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companySPATIAL FRONT INC
Business types and certifications
Women-ownedWomen-owned small business (WOSB)Economically disadvantaged WOSB (EDWOSB)Minority-ownedSelf-certified small disadvantaged businessSBA 8(a) program participantFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Rockville, Montgomery County, Maryland 20857-0001
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R408SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Labor hoursZ
Contract details
- Major program
- Blanket purchase agreement (BPA) - fda information technology program and project management support
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jan 9, 2024Base obligation at award: $1,799,907
- Latest action
- Oct 28, 2026 — Other administrative actionModification P00004; administrative: no change in scope or value
- Latest substantive action
- Dec 17, 2025 — Option exercisedModification P00003; obligation change +$1,299,875
- Actions by type
- Base award1
- Option exercised2
- Other administrative action2
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and all options
- $1,299,864
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- Yes
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $700,000
- COVID-19 supplemental outlays
- $594,564